Abstract:Objective To determine the effect of carnitine palmitoyl-transferase 1A（CPT1A） on renal interstitial fibrosis in diabetic kidney disease（DKD）. Methods A total of 16 4-week-old male C57BL/6 mice were randomly divided into Control（Ctrl） group（n=8） and DKD group（n=8）. The mice of Ctrl group were fed with normal diet, and those from the DKD group were inflicted with intraperitoneal streptozotocin injection plus high fat diet（STZ/HFD） to induce DKD model. Their 24-hour urine were collected, and fasting blood glucose level and body weight were measured every 4 weeks. After 16 weeks of modeling, the mice（aged 20 weeks） were sacrificed, and the levels of serum creatinine, urine creatinine and urine albumin were measured. PAS and Masson stainings were used to analyze the renal glomerulus morphology and interstitial fibrosis. Immunohistochemical assay and Western blotting were performed to detect the expression of CPT1A and fibrosis markers. In in vitro study, human proximal tubular epithelial HK-2 cells were divided into Ctrl group, HG group（30 mmol/L glucose treatment）, and M group（30 mmol/L mannitol treatment）. After treatment for 48 h, the protein levels of CPT1A and fibrosis markers were detected with Western blotting. After HK-2 cells were transfected with CPT1A overexpression plasmid and then treated with 30 mmol/L glucose, cell morphological changes and the expression of CPT1A and fibrosis markers were observed. Results The mice of the DKD group had obvious glomerulus hypertrophy, mesangial expansion and renal interstitial fibrosis, increased levels of serum creatinine and urine albumin/creatinine ratio（P＜0.05）, decreased CPT1A expression, and elevated protein levels of fibrosis markers when compared with the mice of the Ctrl group. In in vitro experiment, HG treatment induced the morphological changes of HK-2 cells into long spindle-shape, decreased level of CPT1A, and increased levels of fibrosis markers, which were not affected by alterations of osmotic pressure. However, CPT1A overexpression significantly reversed these HG-induced morphological changes and high expression of fibrosis markers. Conclusion Overexpression of CPT1A may show potential inhibitory effect on renal interstitial fibrosis in DKD mice.

KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease

KIM-1 Mediated Tubular Fatty Acid Uptake Leads to Progressive Diabetic Kidney Disease

MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease Via the Mechanism

MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease via the PACS-2-Dependent Mechanism

The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential

A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury

Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease

CPT1A Protects Podocytes from Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo

Blood Kidney Injury Molecule-1 is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes.

<b>CPT1A Protects Podocytes from Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo</b><b>The role of CPT1A in diabetic kidney disease</b>

KIM-1-mediated Phagocytosis Reduces Acute Injury to the Kidney.

9-LB: PDZK1 Inhibits Fatty Acid Uptake in Renal Tubular Epithelial Cell Through FATP2 to Ameliorate Diabetic Kidney Disease

Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway

Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease

Targeting VE-PTP phosphatase protects the kidney from diabetic injury

The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression

SB-525334 ameliorates renal injury in diabetic kidney disease mouse model via suppressing inflammation

Lipin-1 Deficiency Deteriorates Defect of Fatty Acid Β-Oxidation and Lipid-Related Kidney Damage in Diabetic Kidney Disease.

CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease

387-P: Novel Mitochondrial Complex I Modulator Reduces Diabetes-Associated Expression of Inflammation and Fibrosis Markers in Human Proximal Tubular Epithelial Cells

Molecular pathways that drive diabetic kidney disease